Quotient Limited Announces Appointment of Chief Financial Officer

Rhea-AI Summary

Quotient Limited (NASDAQ: QTNT) has appointed Ali Kiboro as the new Chief Financial Officer (CFO), effective November 1, 2021. He replaces Peter Buhler, who will assist during the transition before departing at year-end. Kiboro brings over 20 years of global finance experience, including a notable tenure at Quest Diagnostics. CEO Manuel O. Méndez expressed confidence in Kiboro’s abilities to drive revenue growth and execute corporate strategy. Quotient focuses on transforming transfusion diagnostics with its innovative MosaiQ technology.

Positive

• Appointment of Ali Kiboro as CFO expected to strengthen leadership team.
• Kiboro has over 20 years of finance experience, enhancing operational excellence.
• Experience at Quest Diagnostics may provide valuable insights for growth.

Negative

• Transition leadership may cause temporary disruption in financial strategies.

JERSEY, Channel Islands, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Ali Kiboro as the Company’s Chief Financial Officer (CFO). Mr. Kiboro will assume the responsibilities of CFO on November 1^st, 2021, replacing Mr. Peter Buhler who will support the Company during the transitional phase, as needed, before leaving Quotient Limited at year-end.

“I am delighted to welcome Ali to the Executive team at this exciting time in our Company’s evolution. He brings over 20 years of experience in global finance and has been a key driver of operational excellence in a career spanning healthcare services and manufacturing. I worked with Ali at Quest and was impressed by his compelling track record of driving results and building a global finance organization. With Ali’s appointment, we have a strong management team in place to continue to drive revenue growth and the successful execution of our corporate strategy. I would also like to thank Peter for his ongoing commitment and dedication to Quotient,” said Manuel O. Méndez, Chief Executive Officer of Quotient. 

Ali joins the Company from Quest Diagnostics (NYSE: DGX), where he most recently served as Vice President, Finance supporting the Commercial organization. Over a 12-year career at Quest, Ali has assumed finance positions of increasing responsibility supporting Quest’s strategy around Hospitals, Health Plans, Global Markets, Oncology and Anatomic Pathology, Professional Lab Services and Clinical Trials.

Ali started his career as a financial analyst with General Motors (GM) in 1997. He moved to GM Treasurer’s Office in roles in the US and Europe covering capital markets, corporate strategy, capital planning, mergers and acquisitions, pension and healthcare funding, and investor relations. 

Ali holds an MBA in Finance from The Wharton School at the University of Pennsylvania and a BS in Finance from Duquesne University.

“I am very excited and honored to join Quotient at this important phase of the company’s journey to transform transfusion diagnostics and beyond. I look forward to bringing my experience in global finance and operations to execute on our strategy and deliver value to shareholders,” said Mr. Kiboro. 

About Quotient Limited

Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and create operational cost savings to laboratories around the world. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania. The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

CONTACT: Investor Relations, ir@quotientbd.com; +41 22 545 52 26

FAQ

Who is the new CFO of Quotient Limited?

Ali Kiboro has been appointed as the Chief Financial Officer of Quotient Limited.

When will Ali Kiboro assume the role of CFO at Quotient?

Ali Kiboro will assume the responsibilities of CFO on November 1, 2021.

What previous experience does Ali Kiboro bring to Quotient?

Ali Kiboro has over 20 years of experience in global finance, including significant roles at Quest Diagnostics.

What impact might Kiboro's appointment have on Quotient's strategy?

Kiboro's experience is expected to support revenue growth and the execution of Quotient's corporate strategy.

What will happen to Peter Buhler after the transition?

Peter Buhler will assist Quotient during the transitional phase before leaving the company at year-end.